Cyclodextrin drug carrier systems

被引：1926

作者：

Uekama, K ^{[1
]}

Hirayama, F ^{[1
]}

Irie, T ^{[1
]}

机构：

[1] Kumamoto Univ, Fac Pharmaceut Sci, Kumamoto 8620973, Japan

来源：

CHEMICAL REVIEWS | 1998年 / 98卷 / 05期

关键词：

D O I：

10.1021/cr970025p

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：2045 / 2076

页数：32

共 349 条

[31] RECOGNITION ABILITY AND CYTOTOXICITY OF SOME OLIGOSACCHARIDYL SUBSTITUTED BETA-CYCLODEXTRINS [J].

ATTIOUI, F ;

ALOMAR, A ;

LERAY, E ;

PARROTLOPEZ, H ;

FINANCE, C ;

BONALY, R .

BIOLOGY OF THE CELL, 1994, 82 (2-3) :161-167

[32]

ATWOOD JL, 1996, COMPREHENSIVE SUPRAM, V3

[33]

BACHINSKY WB, 1995, J CLIN INVEST, V96, P258

[34] Minimization of Shaking-induced Formation of Insoluble Aggregates of Insulin by Cyclodextrins [J].

Banga, A. K. ;

Mitra, R. .

JOURNAL OF DRUG TARGETING, 1993, 1 (04) :341-345

[35] The blood-brain barrier: Principles for targeting peptides and drugs to the central nervous system [J].

Begley, DJ .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (02) :136-146

[36]

Bender M.L., 1978, Cyclodextrin Chemistry

[37] ORAL PHARMACOKINETICS OF CARBAMAZEPINE IN DOGS FROM COMMERCIAL TABLETS AND A CYCLODEXTRIN COMPLEX [J].

BETLACH, CJ ;

GONZALEZ, MA ;

MCKIERNAN, BC ;

NEFFDAVIS, C ;

BODOR, N .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (10) :1058-1060

[38]

BODOR N, 1985, DESIGN PRODRUGS, P333

[39]

Brange J., 1994, STABILITY INSULIN

[40] USE OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN AS A SOLUBILIZING AND STABILIZING EXCIPIENT FOR PROTEIN DRUGS [J].

BREWSTER, ME ;

HORA, MS ;

SIMPKINS, JW ;

BODOR, N .

PHARMACEUTICAL RESEARCH, 1991, 8 (06) :792-795

← 1 2 3 4 5 6 7 8 9 10 →